share_log

【BT财报瞬析】嘉事堂2023中报:营业收入稳步增长,现金流量净额大幅提升

[Instant Analysis of BT Financial Report] Jiashitang's 2023 Interim Report: Operating income has increased steadily, net cash flow has increased dramatically

businesstimes cn ·  09/15/2023 16:33

Jiashitang (Stock Code: 002462) 2023 interim report has been released. This article will interpret its financial data from the perspective of financial analysts.

First of all, let's take a look at the operating income of Jiashitang. Operating income during the reporting period was 14877717780.55 yuan, an increase of 17.09% compared with 12706434721.05 yuan in the same period last year. This is mainly due to the increase in operating income of the pharmaceutical wholesale business.

However, the net profit attributed to shareholders of listed companies during the reporting period was 155489204.07 yuan, down 8.26% from 169486663.20 yuan in the same period last year. Similarly, net profit after deducting non-recurring gains and losses belonging to shareholders of listed companies also declined, falling 7.87 per cent to 149081767.85 yuan in the reporting period, compared with 161822553.18 yuan in the same period last year. This could mean a decline in the company's profitability during the reporting period.

The eighth batch of drug volume procurement has been implemented, the drug equipment volume procurement has continued to speed up and expand, and the industry policy trend is clear, which has a great impact on the pharmaceutical commercial industry; after the price reduction of coronary artery, pacemaker and orthopedic consumables products, the price reduction of electrophysiology and other products has been implemented, which has an impact on the operation of the company. In the face of the policy impact of drug and consumable belt procurement, the company actively responded, increased business research and management coordination, constantly adjusted and optimized product structure and regional layout, deepened upstream products and services, expanded the introduction of new products, and expanded terminal sales. Effectively hedge and reduce the impact of price reduction of drugs and consumables. At the same time, actively take measures to explore the development of innovative business, cultivate business growth and profit growth points. In the first half of the year, the company took more proactive measures to strengthen the management of accounts receivable and try its best to reduce its impact on the company's operating profits.

It is worth noting that the net cash flow generated by operating activities during the reporting period was 851290876.21 yuan, an increase of 173.54% compared with-1157613569.68 yuan in the same period last year. It is mainly due to the company's strengthening the management of accounts receivable and the increase in the recovery of payment.

In terms of shareholder return, both basic earnings per share and diluted earnings per share during the reporting period were 0.53 yuan per share, down 8.62 percent from 0.58 yuan per share in the same period last year. At the same time, the weighted average return on net assets in the reporting period was 3.78%, down 0.34% from 4.12% in the same period last year. This may have an impact on investors' return on investment.

In terms of assets, the total assets at the end of this report were 16929216099.46 yuan, an increase of 2.25% compared with 16556608348.72 yuan at the end of the previous year. At the same time, the net assets belonging to shareholders of listed companies at the end of this report were 4143082996.40 yuan, an increase of 1.6% compared with 4078022999.53 yuan at the end of last year. This indicates that the asset size of Jiashitang has expanded during the reporting period.

For the cash flow statement, the net cash flow generated by investment activities during the reporting period was-15438134.02 yuan, which was lower than that of-12660528.18 yuan in the same period last year, mainly due to the increase in investment payments. The net cash flow generated by fund-raising activities was-404890484.51 yuan, a large change compared with 353607134.16 yuan in the same period last year, mainly due to an increase in loan repayment to banks and minority shareholders compared with the same period last year.

Based on the above analysis, although the operating income of Jiashitang increased and the net cash flow increased significantly during the reporting period, the indicators such as net profit and earnings per share declined, indicating a decline in the company's profitability. When considering investment, investors should comprehensively consider the financial indicators and operating conditions of the company.

This article only represents the judgment made by the analyst himself or the analyst on the basis of AI analysis, and can not be used as any investment index, nor does it constitute any investment advice. The original intention of this paper is to help investors analyze and judge the capital market data in the most intuitive and fast way and from the most professional perspective.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment